- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying
Global Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying
Results
6
0 new
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
6 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ALIF B | SEK 155.60 | 1.9% | 77.8% | SEK 19.0b | SEK 168.00 | PE160.7x | E55.2% | 0.3% | ||
NEU | AU$20.17 | -2.5% | 55.6% | AU$2.6b | AU$28.68 | PE16.4x | E3.4% | n/a | ||
BIOG B | SEK 126.00 | 2.4% | 23.8% | SEK 12.7b | SEK 150.00 | PE31.7x | E6.7% | 5.5% | ||
DXRX | UK£1.31 | -1.5% | 35.8% | UK£110.6m | UK£1.75 | PS4.7x | E72.2% | n/a | ||
BIOT | SEK 189.30 | 2.2% | 43.4% | SEK 15.1b | SEK 191.00 | PE60.3x | E19.9% | 0.8% | ||
MARKSANS | ₹200.32 | 8.1% | 72.6% | ₹90.8b | ₹240.00 | PE28.9x | E20.7% | 0.3% |
Page 1 of 1